Hydroxychloroquine retinopathy: screening needed to prevent blindness

Trevor J P Hodson
Med J Aust 2011; 194 (1): . || doi: 10.5694/j.1326-5377.2011.tb04161.x
Published online: 3 January 2011

To the Editor: I note the letter in the 7 June issue of the Journal by Ojaimi and colleagues, in which they express their concerns about the lack of uniform screening guidelines for patients on hydroxychloroquine therapy.1 The most obvious problem was the apparent failure of the treating rheumatologist to ensure that the patient was adequately followed up for ocular side effects associated with this treatment.

  • Trevor J P Hodson

  • Mount Gambier Eye Centre, Mount Gambier, SA.



remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.